Profile data is unavailable for this security.
About the company
Bausch Health Companies Inc. is a global, diversified specialty pharmaceutical and medical device company. Its comprehensive portfolio of over 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter (OTC) products and ophthalmic surgical devices and instruments. The Salix segment consists of sales in the U.S. of gastroenterology products. The International segment consists of sales, except for sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Diversified segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Bausch + Lomb segment includes Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products.
- Revenue in CAD (TTM)13.32bn
- Net income in CAD-54.75m
- Incorporated2013
- Employees20.70k
- LocationBausch Health Companies Inc2150 St. Elzear Blvd. WestLAVAL H7L 4A8CanadaCAN
- Phone+1 (514) 744-6792
- Fax+1 (514) 744-6792
- Websitehttps://www.bauschhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Twist Bioscience Corp | 475.99m | -261.69m | 3.12bn | 923.00 | -- | 5.17 | -- | 6.55 | -3.26 | -3.26 | 5.90 | 7.35 | 0.5355 | 7.23 | 8.09 | 376,684.70 | -29.44 | -28.50 | -33.07 | -31.56 | 46.70 | 39.40 | -54.98 | -93.82 | 4.24 | -- | 0.00 | -- | 27.69 | 41.91 | -2.01 | -- | -19.22 | -- |
Vimian Group AB | 624.46m | 30.83m | 3.13bn | 1.20k | 101.77 | 2.86 | 35.63 | 5.01 | 0.4123 | 0.4123 | 8.37 | 14.69 | 0.375 | 1.76 | 6.48 | 3,633,974.00 | 1.96 | -- | 2.20 | -- | 69.01 | -- | 5.23 | -- | 1.22 | 4.87 | 0.2423 | -- | 12.95 | -- | 88.01 | -- | -- | -- |
Ligand Pharmaceuticals Inc | 248.47m | -181.57m | 3.21bn | 68.00 | -- | 2.95 | -- | 12.94 | -7.12 | -7.12 | 9.73 | 41.27 | 0.1995 | 0.7255 | 5.42 | 2,668,941.00 | -14.58 | 1.82 | -15.22 | 1.92 | 92.81 | 82.57 | -73.07 | 10.30 | 5.02 | -0.2833 | 0.00003 | 0.00 | 27.28 | 6.80 | -107.49 | -- | -6.53 | -- |
Bausch Health Companies Inc | 13.32bn | -54.75m | 3.24bn | 20.70k | -- | -- | 2.02 | 0.2436 | -0.1486 | -0.1486 | 36.07 | -4.38 | 0.3649 | 1.75 | 4.72 | 643,468.30 | -0.3038 | -1.66 | -0.3786 | -2.06 | 70.78 | 71.26 | -0.8324 | -5.56 | 0.9678 | 1.36 | 1.01 | -- | 9.91 | 2.28 | 92.23 | -- | 4.11 | -- |
Apellis Pharmaceuticals Inc | 1.06bn | -306.23m | 3.34bn | 705.00 | -- | 14.88 | -- | 3.15 | -1.79 | -1.79 | 6.23 | 1.31 | 0.9466 | 1.08 | 3.08 | 1,100,482.00 | -27.29 | -61.31 | -35.92 | -76.53 | 83.00 | 86.49 | -28.83 | -157.26 | 3.62 | -5.43 | 0.7341 | -- | 97.02 | -- | 62.57 | -- | -24.96 | -- |
Nanjing King-Frind Bchmcl Phrmctcl C Ltd | 726.59m | 140.12m | 3.38bn | 1.36k | 24.11 | 2.69 | -- | 4.65 | 0.4546 | 0.4546 | 2.35 | 4.07 | 0.4099 | 0.6049 | 4.16 | 2,797,451.00 | 7.90 | 8.38 | 10.35 | 12.03 | 41.78 | 44.95 | 19.28 | 19.72 | 2.09 | 56.95 | 0.1858 | 23.22 | -0.1984 | 9.70 | 536.09 | 6.43 | 34.44 | -6.04 |
Liaoning Cheng Da Co Ltd | 2.18bn | 89.57m | 3.41bn | 3.32k | 37.17 | 0.6027 | -- | 1.56 | 0.3137 | 0.3137 | 7.45 | 19.35 | 0.2373 | 5.00 | 6.41 | 3,436,062.00 | 2.05 | 3.15 | 2.94 | 4.55 | 12.77 | 13.95 | 8.64 | 9.88 | 0.863 | -- | 0.2759 | 16.44 | 4.70 | -8.65 | -10.09 | -29.33 | -9.31 | -27.52 |